# 2025-21189: Importer of Controlled Substances Application: Fisher Clinical Services, Inc.

2025-21189, Importer of Controlled Substances Application: Fisher Clinical Services, Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-11-26, effective Registered bulk manufacturers and applicants may submit comments or objections, or file a written request for a hearing, on or before December 26, 2025. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-21189
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-21189
- Title: Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 54380
- Published: 2025-11-26
- Effective: Registered bulk manufacturers and applicants may submit comments or objections, or file a written request for a hearing, on or before December 26, 2025.
- Comments close: 2025-12-26
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## Summary

Fisher Clinical Services, Inc. wants to become an official importer of certain controlled substances like marijuana and its extracts. This affects companies involved in drug manufacturing and importation, who can comment or request a hearing by December 26, 2025. No direct costs are mentioned, but the decision could impact how these substances enter the U.S. market.

## Abstract

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- Deadline to Comment or Request Hearing: benefit, low. If you are a registered bulk manufacturer or an applicant, you may submit electronic comments or objections, or file a written request for a hearing, by December 26, 2025. Comments must be submitted through https://www.regulations.gov and hearing requests must also be mailed to the Drug Enforcement…
- Application to Import Specific Controlled Substances: benefit, low. Fisher Clinical Services, Inc. applied on August 26, 2025 to be registered to import specific Schedule I and II substances — including marihuana, marihuana extract, tetrahydrocannabinols, 5‑MeO‑DMT, DMT, psilocybin, methylphenidate, levorphanol, noroxymorphone, and tapentadol — and says it plans to…
- No Commercial Finished Dosage Imports Allowed: cost, medium. The registration, if approved, will not authorize importation of Food and Drug Administration‑approved or non‑approved finished dosage forms for commercial sale; approval is limited to activities consistent with 21 U.S.C. 952(a)(2).

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-21189 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/26/2025-21189/importer-of-controlled-substances-application-fisher-clinical-services-inc)
- [2025-21189 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-26/pdf/2025-21189.pdf)

## Related
- [Previous: 2025-21188, Proposal Review; Notice of Meetings](https://policyrisk.com/federal-register/2025-21188)
- [Next: 2025-21190, Bulk Manufacturer of Controlled Substances Application: National Center for Nat…](https://policyrisk.com/federal-register/2025-21190)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-21189 (as of 2026-06-08).
